Newt’s World Episode 75: COVID-19 Health Care Breakthroughs – Clinical Trials Hydroxychloroquine
As doctors and clinicians continue to look for breakthroughs in treatments for COVID-19, could the anti-malarial drug, hydroxychloroquine, prove to be a possible prophylactic? Newt talks with Dr. David Pearce of Sanford Health. Sanford Health is conducting the first controlled hydroxychloroquine clinical trial in the United States.
As doctors and clinicians continue to look for breakthroughs in treatments for COVID-19, could the anti-malarial drug, hydroxychloroquine, prove to be a possible prophylactic? Newt talks with Dr. David Pearce of Sanford Health. Sanford Health is conducting the first controlled hydroxychloroquine clinical trial in the United States.][vc
GUEST – DR. DAVID PEARCE
ARTICLES
FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems – FDA
Emergency Use Authorization for Use of Chloroquine Phosphate or Hydroxychloroquine Sulfate Supplied From the Strategic National Stockpile for Treatment of 2019 Coronavirus Disease – FDA
